logging in or signing up Agonists in Neuroanesthesia aSGuest33692 Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 223 Category: Others/ Misc License: All Rights Reserved Like it (0) Dislike it (0) Added: December 08, 2009 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript Intraoperative Use of a2- Agonists in Neuroanesthesia : Intraoperative Use of a2- Agonists in Neuroanesthesia Alex Bekker M.D., Ph.D. Director of Neuroanesthesia New York University School of Medicine Slide 2: Progress may have been all right once, but it went on too long. Ogden Nash Activation of a2-receptors leads to: : Activation of a2-receptors leads to: Dose dependent sedation and anxiolysis Analgesia (supraspinal and spinal sites) Decrease plasma catecholamines Centrally mediated bradycardic and hypotensive effects Diuresis due to inhibition of ADH release and antagonism of ADH tubular effects Decongestant and antisialogogue effects Qualifications for inclusion into the neuroanesthesia drug club: : Qualifications for inclusion into the neuroanesthesia drug club: Controllability (e.g. rapid onset and offset of effect) Stability of intracranial homeostasis Hemodynamic stability Noninterference with neurophysiologic monitoring Neuroprotection Antinonociception Pharmacokinetics of IV agents : Pharmacokinetics of IV agents Slide 6: Context-sensitive Dexmedetomidine recovery times as a function of duration of infusion Effect of Dexmedetomidine on Cerebral Blood Flow : Effect of Dexmedetomidine on Cerebral Blood Flow Animal models Dex causes a reduction in CBF up to 45% Dex has no effect on the CMRO2 Dex produces the concentration-dependent constriction of pial arteries and veins Dex limits hypercapnea- and hypoxia-induced cerebral vasodilation Zornow MH et al, Anesth Analg; 1990 Fale A et al, Anesth Analg; 1994 Karlsson et al, Anesth Analg; 1991 Effect of Dexmedetomidine on Cerebral Blood Flow : Effect of Dexmedetomidine on Cerebral Blood Flow Human study (TCD) Mean CBF velocity decreased with an increase in plasma concentration of Dex Pulsatility index increased at higher level of Dex (indicates an increase in CVR) Zornow MH et al, J Cereb Blood Flow Metab; 1993 Effect of Dexmedetomidine on ICP : Effect of Dexmedetomidine on ICP Animal model ICP was unchanged despite an increase in systemic blood pressure in rabbits ICP was decreased in the presence of intracranial hypertension Zornow MH et al, Anesth Analg 1992 Human study Dex has no effect on lumbar CSF pressure in patients undergoing transphenoidal pituitary tumor resection Talke P et al. Anesth Analg 1997 Dexmedetomidine effect on SSEPs and AEP : Dexmedetomidine effect on SSEPs and AEP There is a lack of effect on cortical AEP Dex does not affect cortical (P25-N35) response Dex depresses median nerve P15-N20 amplitudes Thornton C et al. Br J Anaesth 1999 Median nerve SSEPs tracings after switching from propofol to Dexmedetomidine infusion : Median nerve SSEPs tracings after switching from propofol to Dexmedetomidine infusion Left Right Amplitudes of early and late SSEP waves at various stages of the surgery : Amplitudes of early and late SSEP waves at various stages of the surgery Dexmedetomidine effect on the EEG : Dexmedetomidine effect on the EEG Dex decreased MPF and 95% PF in cats Dex increased delta band power Halothane 2% produced similar EEG changes Animals on Dex responded to tail clamping purposefully BIS values after Dex infusion for 1 hour were: 65 at 0.2 mg/kg/hr 60 at 0.6 mg/kg/hr The volunteers were readily awakened from hypnosis by talking to them; BIS returned to awake level Farber NE et al. Brain Research 1997 Hall JE et al. Anesth Analg 2000 Slide 14: BIS before and after subjects were asked to perform various tasks Hall et al. Anesth Analg 2000 Neuroprotective effects of Dexmedetomidine : Neuroprotective effects of Dexmedetomidine Inhibition of ischemia induced NE release may be associated with neuroprotection Dex prevents delayed neuronal death after focal ischemia Dex decreased total ischemic volume by 40% compared to placebo Jolkkonen J et al. Euro J Pharm 1999 Hoffman WE et al Anesthesiology 1991 Dex enhances glutamine disposal by oxydative metabolism in astrocytes Huang R et al. J Cereb Blood Metab 2000 Dexmedetomidine and Antinociception : Dexmedetomidine and Antinociception a2 – Agonists attenuate hemodynamic responses to laryngoscopy and intubation Lawrence CJ et al Anaesthesia 1997 a2 – Agonists decrease perioperative oxygen consumption Taittonen MT Br J Anaesth 1997 Dex reduces NE level during emergence from anesthesia (2 to 3 times lower than in placebo group) Talke P et al. Anesth Analg 2000 Law of Conservation of Tsouris : Law of Conservation of Tsouris The amount of aggravation in the universe is a constant. If things are going well in one area, they are going wrong in another. Dexmedetomidine: Side Effects : Dexmedetomidine: Side Effects Hypotension Transient hypertension Bradycardia Dry mouth Limited amnestic effect Animal studies show reduction in the CBF/CMRO2 ratio Excessive sedation Clinical Experience: Craniotomy : Clinical Experience: Craniotomy In patient undergoing craniotomy, premedication with clonidine: reduced anesthetic requirements attenuated hemodynamic responses to intubation and pin fixation Costello T et al Anesth Analg 1998 Postoperative infusion of Dex in patients recovering from transphenoidal hypophysectomy reduced plasma catecholamines by 70% Talke P et al Anesth Analg 1997 Clinical Experience: Spinal Fusion : Clinical Experience: Spinal Fusion Perioperative administration of clonidine reduced postoperative morphine requirements by a factor of 3 in patients undergoing spinal fusion Bernard et al Anesthesiology 1991 Intraoperative switching from a propofol infusion to Dex in patients undergoing cervical fusion resulted in: A neurological examination that was successfully performed in the OR on an intubated patient Clinically insignificant hemodynamic changes during and after the switchover Bloom M et al J Neurosurg Anesth 2001 a2 – Agonists and Cognitive Function : a2 – Agonists and Cognitive Function There is strong evidence that a2 – agonists improve prefrontal cortical function (PFC) PFC shares reciprocal projections with: Parietal association cortex specialized for visuospatial processing Medial temporal lobe important to memory abilities Anterior cingulate cortex involved in organizing complex cognitive function Caudate nucleus that regulates motor behavior NE’s beneficial action in the PFC appear to result from stimulation of a2 (A) – receptors postjunctional to NE terminals Arnstein et el. Arch Gen Psychiatry 1996 Clinical Experience: Carotid Endartrectomy : Clinical Experience: Carotid Endartrectomy A combination of superficial and deep cervical plexus blocks is the most common regional anesthetic technique in the NYU medical center Sedation with dexmedetomidine (0.2-0.4 mcg/kg/hr) offers a comfortable and cooperative patient during the operation Less agitation and respiratory depression than with a continuous infusion of propofol or repeated doses of fentanyl and/or midazolam Clinical Experience: Functional Neurosurgery : Clinical Experience: Functional Neurosurgery Dex infusion at 0.1 – 0.2 mg/kg/hr allowed us to achieve a tranquil state sufficient to complete neuropsychiatric testing required for mapping of the cortical speech area, as well as to perform an awake tumor resection A lack of respiratory depression offers an advantage over other technique Bekker A et al. Anesth Analg 2001 Is there a reason to add Dexmedetomidine to our practice? : Is there a reason to add Dexmedetomidine to our practice? Dex properties include: Reversible sedation without respiratory depression Analgesia Anesthetic sparing effect Cardiovascular stability Has minimal effect on ICP May offer neuroprotection A unique type of sedation in which a patient could be aroused readily Theoretical advantages have to be objectively justified in clinical studies You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.
Agonists in Neuroanesthesia aSGuest33692 Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 223 Category: Others/ Misc License: All Rights Reserved Like it (0) Dislike it (0) Added: December 08, 2009 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript Intraoperative Use of a2- Agonists in Neuroanesthesia : Intraoperative Use of a2- Agonists in Neuroanesthesia Alex Bekker M.D., Ph.D. Director of Neuroanesthesia New York University School of Medicine Slide 2: Progress may have been all right once, but it went on too long. Ogden Nash Activation of a2-receptors leads to: : Activation of a2-receptors leads to: Dose dependent sedation and anxiolysis Analgesia (supraspinal and spinal sites) Decrease plasma catecholamines Centrally mediated bradycardic and hypotensive effects Diuresis due to inhibition of ADH release and antagonism of ADH tubular effects Decongestant and antisialogogue effects Qualifications for inclusion into the neuroanesthesia drug club: : Qualifications for inclusion into the neuroanesthesia drug club: Controllability (e.g. rapid onset and offset of effect) Stability of intracranial homeostasis Hemodynamic stability Noninterference with neurophysiologic monitoring Neuroprotection Antinonociception Pharmacokinetics of IV agents : Pharmacokinetics of IV agents Slide 6: Context-sensitive Dexmedetomidine recovery times as a function of duration of infusion Effect of Dexmedetomidine on Cerebral Blood Flow : Effect of Dexmedetomidine on Cerebral Blood Flow Animal models Dex causes a reduction in CBF up to 45% Dex has no effect on the CMRO2 Dex produces the concentration-dependent constriction of pial arteries and veins Dex limits hypercapnea- and hypoxia-induced cerebral vasodilation Zornow MH et al, Anesth Analg; 1990 Fale A et al, Anesth Analg; 1994 Karlsson et al, Anesth Analg; 1991 Effect of Dexmedetomidine on Cerebral Blood Flow : Effect of Dexmedetomidine on Cerebral Blood Flow Human study (TCD) Mean CBF velocity decreased with an increase in plasma concentration of Dex Pulsatility index increased at higher level of Dex (indicates an increase in CVR) Zornow MH et al, J Cereb Blood Flow Metab; 1993 Effect of Dexmedetomidine on ICP : Effect of Dexmedetomidine on ICP Animal model ICP was unchanged despite an increase in systemic blood pressure in rabbits ICP was decreased in the presence of intracranial hypertension Zornow MH et al, Anesth Analg 1992 Human study Dex has no effect on lumbar CSF pressure in patients undergoing transphenoidal pituitary tumor resection Talke P et al. Anesth Analg 1997 Dexmedetomidine effect on SSEPs and AEP : Dexmedetomidine effect on SSEPs and AEP There is a lack of effect on cortical AEP Dex does not affect cortical (P25-N35) response Dex depresses median nerve P15-N20 amplitudes Thornton C et al. Br J Anaesth 1999 Median nerve SSEPs tracings after switching from propofol to Dexmedetomidine infusion : Median nerve SSEPs tracings after switching from propofol to Dexmedetomidine infusion Left Right Amplitudes of early and late SSEP waves at various stages of the surgery : Amplitudes of early and late SSEP waves at various stages of the surgery Dexmedetomidine effect on the EEG : Dexmedetomidine effect on the EEG Dex decreased MPF and 95% PF in cats Dex increased delta band power Halothane 2% produced similar EEG changes Animals on Dex responded to tail clamping purposefully BIS values after Dex infusion for 1 hour were: 65 at 0.2 mg/kg/hr 60 at 0.6 mg/kg/hr The volunteers were readily awakened from hypnosis by talking to them; BIS returned to awake level Farber NE et al. Brain Research 1997 Hall JE et al. Anesth Analg 2000 Slide 14: BIS before and after subjects were asked to perform various tasks Hall et al. Anesth Analg 2000 Neuroprotective effects of Dexmedetomidine : Neuroprotective effects of Dexmedetomidine Inhibition of ischemia induced NE release may be associated with neuroprotection Dex prevents delayed neuronal death after focal ischemia Dex decreased total ischemic volume by 40% compared to placebo Jolkkonen J et al. Euro J Pharm 1999 Hoffman WE et al Anesthesiology 1991 Dex enhances glutamine disposal by oxydative metabolism in astrocytes Huang R et al. J Cereb Blood Metab 2000 Dexmedetomidine and Antinociception : Dexmedetomidine and Antinociception a2 – Agonists attenuate hemodynamic responses to laryngoscopy and intubation Lawrence CJ et al Anaesthesia 1997 a2 – Agonists decrease perioperative oxygen consumption Taittonen MT Br J Anaesth 1997 Dex reduces NE level during emergence from anesthesia (2 to 3 times lower than in placebo group) Talke P et al. Anesth Analg 2000 Law of Conservation of Tsouris : Law of Conservation of Tsouris The amount of aggravation in the universe is a constant. If things are going well in one area, they are going wrong in another. Dexmedetomidine: Side Effects : Dexmedetomidine: Side Effects Hypotension Transient hypertension Bradycardia Dry mouth Limited amnestic effect Animal studies show reduction in the CBF/CMRO2 ratio Excessive sedation Clinical Experience: Craniotomy : Clinical Experience: Craniotomy In patient undergoing craniotomy, premedication with clonidine: reduced anesthetic requirements attenuated hemodynamic responses to intubation and pin fixation Costello T et al Anesth Analg 1998 Postoperative infusion of Dex in patients recovering from transphenoidal hypophysectomy reduced plasma catecholamines by 70% Talke P et al Anesth Analg 1997 Clinical Experience: Spinal Fusion : Clinical Experience: Spinal Fusion Perioperative administration of clonidine reduced postoperative morphine requirements by a factor of 3 in patients undergoing spinal fusion Bernard et al Anesthesiology 1991 Intraoperative switching from a propofol infusion to Dex in patients undergoing cervical fusion resulted in: A neurological examination that was successfully performed in the OR on an intubated patient Clinically insignificant hemodynamic changes during and after the switchover Bloom M et al J Neurosurg Anesth 2001 a2 – Agonists and Cognitive Function : a2 – Agonists and Cognitive Function There is strong evidence that a2 – agonists improve prefrontal cortical function (PFC) PFC shares reciprocal projections with: Parietal association cortex specialized for visuospatial processing Medial temporal lobe important to memory abilities Anterior cingulate cortex involved in organizing complex cognitive function Caudate nucleus that regulates motor behavior NE’s beneficial action in the PFC appear to result from stimulation of a2 (A) – receptors postjunctional to NE terminals Arnstein et el. Arch Gen Psychiatry 1996 Clinical Experience: Carotid Endartrectomy : Clinical Experience: Carotid Endartrectomy A combination of superficial and deep cervical plexus blocks is the most common regional anesthetic technique in the NYU medical center Sedation with dexmedetomidine (0.2-0.4 mcg/kg/hr) offers a comfortable and cooperative patient during the operation Less agitation and respiratory depression than with a continuous infusion of propofol or repeated doses of fentanyl and/or midazolam Clinical Experience: Functional Neurosurgery : Clinical Experience: Functional Neurosurgery Dex infusion at 0.1 – 0.2 mg/kg/hr allowed us to achieve a tranquil state sufficient to complete neuropsychiatric testing required for mapping of the cortical speech area, as well as to perform an awake tumor resection A lack of respiratory depression offers an advantage over other technique Bekker A et al. Anesth Analg 2001 Is there a reason to add Dexmedetomidine to our practice? : Is there a reason to add Dexmedetomidine to our practice? Dex properties include: Reversible sedation without respiratory depression Analgesia Anesthetic sparing effect Cardiovascular stability Has minimal effect on ICP May offer neuroprotection A unique type of sedation in which a patient could be aroused readily Theoretical advantages have to be objectively justified in clinical studies